Pharmaceutical Technology49 分钟
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co’s ...
Olomorasib is a small molecule commercialized by Eli Lilly and Co, with a leading Phase III program in Non-Small ...
Pharmaceutical Technology54 分钟
Risk adjusted net present value: What is the current valuation of Pfizer’s Ponsegromab?
Ponsegromab is a monoclonal antibody commercialized by Pfizer, with a leading Phase II program in Cancer Anorexia-Cachexia Syndrome.